INVESTOR RELATIONS
A Message to You
Corporate Information
Corporate Fact Sheet
S.E.C. Filings
Annual Reports
Corporate Governance
Investor Contacts
|
|
Product Advancements & Breakthroughs
Heart Tronics, Inc. develops and commercializes state-of-the-art real time monitoring technology. The company’s patented technology addresses a major problem facing the cardiac care market. Distortions of ECG signals due to body movements as well as environmental interferences are greatly reduced with the Heart Tronics ECG System. The Fidelity100, which has received 510 (k) clearance from the FDA, is commercially available for both resting and ambulatory applications.
| • |
Clear, true 12-lead ECG signal recordings while patient is ambulatory |
| • |
Continuous outpatient heart information data available to physicians |
| • |
Allows for recent heart surgery patients to be monitored 24/7 over extended periods |
| • |
Enhances the physicians capability to accurately detect and diagnosis heart disease symptoms |
| • |
Allows for cost effective and more accurate ambulatory patient monitoring for heart attack survivors |
|
|
